Baltimore Orioles Face Early Season Blow With Jordan Westburg Injury
The Baltimore Orioles' concerns regarding infielder Jordan Westburg's health have escalated significantly this week. The club has officially announced that Westburg will be sidelined for a minimum of the first month of the regular season, dealing a substantial blow to their early-season lineup plans.
Diagnosis and Conservative Treatment Plan
Westburg was diagnosed with a partial tear of the ulnar collateral ligament in his right elbow after experiencing discomfort while throwing during spring training activities. Team officials have confirmed that the 27-year-old is expected to be out of action until at least May, but the current plan is to avoid surgical intervention.
The Orioles suspect this may have been a pre-existing issue that only resurfaced during camp, which prompted immediate imaging and a cautious approach from the medical staff. The organization is emphasizing Westburg's long-term health as the absolute priority over any rushed return to the field.
Over the coming weeks, Westburg will receive a platelet-rich plasma injection as part of a conservative treatment strategy focused on healing and reducing inflammation. The Orioles are optimistic that this PRP treatment will facilitate recovery without the need for surgery, which would have potentially jeopardized his entire 2026 season.
Impact on Westburg's Career and Team Role
While the team has not provided a definitive timetable beyond the May target, medical history shows that many players have successfully returned from similar injuries through non-invasive PRP treatments. This development is particularly frustrating for a player of Westburg's caliber.
The former All-Star has emerged as a crucial middle-of-the-order bat for Baltimore, providing significant power, consistent on-base ability, and valuable defensive versatility across multiple infield positions. However, his ability to maintain consistent playing time has been challenged by various injuries since reaching the major leagues.
The Orioles have made it clear they will not allow Westburg to resume game action until medical staff can properly assess his throwing comfort and capability. This careful management underscores his importance to the team's long-term plans.
Orioles Forced to Reshape Infield Strategy
Westburg's absence represents just the latest complication in Baltimore's early-season roster construction. With the regular season approaching and the list of unavailable infielders growing, the Orioles will likely turn to internal options to cover third base and second base during Westburg's rehabilitation period.
The organization plans to extend opportunities to younger players and depth pieces through May, allowing the coaching staff to evaluate long-term compatibility and roster flexibility. While the front office hasn't completely ruled out external additions, they appear inclined toward patience, especially considering Westburg's projected role later in the season.
Baltimore entered spring training seeking stability after last season's unpredictable performance, but injuries are already testing those plans. How effectively the Orioles navigate Westburg's extended absence could become a defining factor in their season's trajectory, forcing early adjustments to their infield configuration and overall team strategy.
